Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$112.16 -1.79 (-1.57%)
At close: Nov 11, 2026 · 4:00 PM EST

Rhythm Pharmaceuticals (RYTM) Gains (Losses) on Sale of Assets & Investments (2020 - 2026)

Updated

Analysis

Rhythm Pharmaceuticals (RYTM) Gains (Losses) on Sale of Assets & Investments (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Rhythm Pharmaceuticals 7.90 Bn 6.52 Bn 79.96 Mn -909,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -909,000.00
Jun 30, 2026 -365,000.00
Mar 31, 2026 -544,000.00
Dec 31, 2025 119,000.00
Sep 30, 2025 488,000.00
Jun 30, 2025 -93,000.00
Mar 31, 2025 -10,000.00
Dec 31, 2024 -412,000.00
Sep 30, 2024 615,000.00
Jun 30, 2024 -134,000.00
Mar 31, 2024 -244,000.00
Dec 31, 2023 436,000.00
Sep 30, 2023 -175,000.00
Jun 30, 2023 40,000.00
Mar 31, 2023 65,000.00
Dec 31, 2022 247,000.00
Sep 30, 2022 267,000.00
Jun 30, 2022 -277,000.00
Mar 31, 2022 -628,000.00
Dec 31, 2021 106,000.00
API Access

Rhythm Pharmaceuticals Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=RYTM&period=max&api_key=YOUR_API_KEY